Serum GM3(d18:1-16:0) and GM3(d18:1-24:1) are novel biomarkers for lymphoma

Masako Nishikawa

Presentation information

Oral Session

Oral Session 1-8C Malignant Lymphoma: Prognostic factors

Fri. Oct 12, 2018 3:10 PM - 4:10 PM No.8 (Osaka International Convention Center, 10F 1002)

Chair: Takashi Watanabe (Department of Immuno-Gene Therapy Mie University Graduate School of Medicine, Japan)

[OS1-8C-6] Serum GM3(d18:1-16:0) and GM3(d18:1-24:1) are novel biomarkers for lymphoma

Masako Nishikawa¹, Makoto Kurano¹, Takahiro Nitta², Hirotaka Kanoh², Jin-Ichi Inokuchi², Yutaka Yatomi¹ (1.Department of Clinical Laboratory Medicine, University of Tokyo, Tokyo, Japan, 2.Division of Glycopathology, Tohoku Medical and Pharmaceutical University, Sendai, Japan)

Abstract password authentication.
Password is written on a program and abstract book.